View All Cardiology Activities Featured Cardio Activities

		Philip Gorelick, MD, MPH, FACP, FAHA, FAAN and colleagues present... Cases in Vascular Protection: Reducing Risk Factors Case 5: Primary and Secondary Prevention of Stroke Released: November 20, 2007 Expires: November 30, 2008	1.00CME

		Jean Nappi, PharmD and colleagues present... Cases in Vascular Protection: Reducing Risk Factors-Case 3: Acute Coronary Syndrome Released: September 12, 2007 Expires: September 12, 2008	1.00CME

		Scott D. Solomon, MD and colleagues present... Vascular Protection Module 3: Metabolic Syndrome Released: November 7, 2007 Expires: November 7, 2008	0.75CME

		Eva Rodriguez, MD and colleagues present... Cases in Vascular Protection: Reducing Risk Factors-Case 4: Chronic Kidney Disease Released: October 1, 2007 Expires: October 31, 2008	1.00CME

Feed Provided by MedWorm.com Cardio News

[global burden of cardiovascular disease] paediatric heart care in india
Determinants of thrombin generation, fibrinolytic activity, and endothelial dysfunction in patients on dual antiplatelet therapy: involvement of factors other than platelet aggregability in virchow's triad
Valvular heart disease: a perspective on the asymptomatic patient with severe valvular aortic stenosis
Inside this issue of jacc
Molecular genetics of atrial fibrillation
Nitrate-induced toxicity and preconditioning: a rationale for reconsidering the use of these drugs

View All Events Cardio Events

a.
Society of Critical Care Medicine
Clinical Focus: Venous Thromboembolism
b.
American Society of Nuclear Cardiology
2008 Annual Meeting
c.
American Association of Cardiovascular and Pulmonary Rehabilitation
2008 Annual Meeting
d.
American College of Chest Physicians
CHEST 2008
e.
American Academy of Medical Administrators
2008 Annual Conference

Optimizing Antiplatelet Therapy in the ACS Patient

2.00CME

This presentation aims to address the central role of platelets in acute coronary syndromes (ACS) and the use of both oral antiplatelet therapy and interventional therapy as cornerstones for the treatment of ACS. Topics to be discussed include the pharmacology of approved and investigational oral antiplatelet agents, clinical trial data detailing the use of these agents post-ACS, and upcoming investigational trials of current as well as novel therapeutic compounds. The use of non-pharmacologic interventional therapies is also addressed, including the optimal use and management of drug-eluting stents.

Read More

Presented By Multiple Faculty Members...
Deepak Bhatt, MD, FACC; Elliott M. Antman, MD, FACC; Stephen D. Wiviott, MD;

Vascular Protection Module 3: Metabolic Syndrome

0.75CME

Many therapies currently exist today for the treatment of hypertension, however, there still remains a critical need to better establish and define the concept of vascular protection. To appreciate this concept, it is important to understand the data which results in a reduction in the risk of... Read More

Presented By Multiple Faculty Members...
Scott D. Solomon, MD; Orly Vardeny, PharmD;

Cases in Vascular Protection: Reducing Risk Factors Case 5: Primary and Secondary Prevention of Stroke

1.00CME

Stroke is a major problem in the United States, with approximately 700,000 individuals experiencing new or recurrent stroke each year. Stroke prevention primarily involves risk factor reduction via lifestyle modifications and often drug therapy to reduce the impact of hypertension, diabetes,... Read More

Presented By Multiple Faculty Members...
Philip Gorelick, MD, MPH, FACP, FAHA, FAAN; Sean Ruland, DO;